Premature Discontinuation of Contraceptive Implants

• Status: Recruiting
• Trial end date: 2023-08-31
• Target enrollment: 0
• Participant gender: Female

Summary

To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (COCR intervention) to participants given standard counseling (comparator).

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Colorado, Denver
• Treatments: Estradiol; Ethinyl Estradiol; Moxifloxacin; Norgestimate; Norgestimate, ethinyl estradiol drug combination

Criteria

Inclusion Criteria:

1. You are between ages of 14 to 22.9 years.

2. Started etonogestrel implant for the first time and have never used the implant before.

Exclusion Criteria:

1. There is any contraindication to estrogen containing birth control.

2. Desire of pregnancy in next 12 months.

3. Plans to move from the area in next 12 months and is not able to come to the clinic.